Comparative study of the effects of captodiamine and lorazepam on car driving ability

Clinical Drug Investigation

Volumn 17, Issue 6, 1999, Pages 451-459

  Mercier Guyon, C ^a   Lejay, J ^b   Choay, P ^b  

^a Ctr d'Etudes et de Rech en M   (France)

^b Laboratoires A BAILLY SPEAB   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CAPTODIAMINE; LORAZEPAM; UNCLASSIFIED DRUG;

ADULT; ALERTNESS; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRIVING ABILITY; DROWSINESS; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL CAPACITY; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; REACTION TIME;

EID: 0032985845     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199917060-00005     Document Type: Article

References (19)

1. 1. Lagier G. Aspects techniques et scientifiques. In Lagier G. editor. Conduite automobile, vigilance et médicaments. Paris: Sejourne-Robert, 1997: 27-100
2. 2. Vermeeren A, De Gier JJ, O'Hanlon JF. Methodological guidelines for experimental research on medicinal drugs affecting driving performance: an international expert survey. J Traffic Med 1994; 22 (4): 173-4
3. 3. Lillsunde P. Commentary, alcohol, drugs users and traffic accidents - a review on epidemiological studies. J Traffic Med 1998; 26 (1-2): 5-10
4. 4. Ferrara SD, Zancaner S, Snenghi R. Psychoactive drugs involvement in traffic accidents in Italy. Proceedings of the 11th International Conference on Alcohol, Drugs and Traffic Safety; 1989 Oct 24-27; Chicago: National Safety Council, 260-4
5. 5. Laurell H, Benzodiazepines and road accidents. Actes de la 3ème Conférence Vigilance et Performances Psychomotrices; 1991 19-10 Avril; Annecy, France. CERMT Ed. Annecy, 1991: 26-9
6. 6. Lechat P, Fatigue, médicaments et conduite automobile. Bull Acad Natl Med 1982; 186 (6): 773-7
7. 7. Berghaus G. Concentration-effect relationship with benzodiazepine therapy. Proceedings of the 14th International Conference on Alcohol, Drugs and Traffic Safety; 1997 Sep 21-26; Annecy, France. CERMT Ed. Annecy, 1997: 705-9
8. 8. Steentoft A. Other drugs than alcohol in Danish traffic cases, requested by the police. Proceedings of the 14th International Conference on Alcohol, Drugs and Traffic Safety; 1997 Sep 21-26; Annecy, France. CERMT Ed. Annecy, 1997: 1345-9
9. 9. Mercier-Guyon C. Médicaments, drogues et comportement au volant. Bull Acad Natl Med 1994; 178 (6); 1111-22
10. 10. Mercier-Guyon C. Tests in sedation and tests in risk taking, their interest and their limits in evaluation of side effects of psychotropic drugs applied to driving. Proceedings of the 12th International Conference on Alcohol, Drugs and Traffic Safety; 1992 Sep 28-Oct 2; Rheinland, Köln, Germany: 725-33
11. 11. Weidmann H, Petersen PV. A new group of potent sedatives. J Pharmacol Exp Ther 1953; 108 (2): 201-16
12. 12. Pentney BH, Brotherwood RW, Captodiamine in anxiety states in general practice. Practitioner 1960; 185: 218
13. 13. Mercier-Guyon C. Methodological aspects in evaluation of the effects of psychotropic drugs and driving. International workshop on drugs and driving; 1991: 29 Oct-1 Nov. University di Padova, Italy. ARFI Ed. 1991: 73-5
14. 14. Mercier-Guyon C, Ducluzeau R, Normand R. Fffects of Valpromide on alertness and psychomotor skills. Proceedings of the 11th International Conference on Alcohol, Drugs and Traffic Safety; 1989 Oct 24-27; Chicago, USA, 889-92. National Safety Council
15. 15. Crocq L, Mercier-Guyon C. Effets de l'association Bromazépam-alcool sur la vigilance et les performances psychomotrices des conducteurs automobiles. Congrès de psychiatrie et de neurologie de langue française, 1989; 3-9 Juillet; Montréal, 496-500
16. 16. Crocq L, Mercier-Guyon C. Etude en double aveugle des effets de l'association Bromazépam-alcool versus placebo chez 11 conducteurs automobiles. C R Ther Pharm Clin 1984; 7 (78): 2-9
17. 17. O'Hanlon JF, Verlmeeren A, Uiterwijk MM, et al. Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies. Neuropsychobiology 1995; 31 (2): 81-8
18. 18. Martindale, The Extra Pharmacopocia. 31st ed, Reynolds editors. The Royal Pharmaceutical Society, London 1996
19. 19. Kay GG, Berman B, Mockoviak SH, et al. Initial and steady state effects of diphenhydramine and loratadine on sedation, cognition, mood and psychomotor performance. Arch Intern Med 1997; 157 (20): 2350-6